SEC Form 4 · accession 0001193125-26-337649
CHEMED CORP · CHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel L Wherley
Officer — CEO - Vitas Healthcare
Period of report
Aug 5, 2026
Accepted (ET)
Aug 6, 2026 · 2:17 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000019584
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Capital Stock | Aug 5, 2026 | M | 2,599 | $445.35 | A | 3,451 | D | |
| Capital Stock | Aug 5, 2026 | F | 2,270 | $542.62 | D | 1,181 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy with tandem tax withholding)F2 | $445.35 | Aug 5, 2026 | M | 2,599 | D | — | Oct 28, 2026 | Capital Stock | 2,599 | 30,220 | D |
Explanation of responses
- F1Payment of purchase price and tax obligation on stock option exercise.
- F2Vesting in three equal annual installments commencing 10/28/2022.